Search

everythinglearnresearchcommunity

for

Search:↓

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Finasteride helps reduce heart issues and improves heart function.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Cutaneous vesicostomy and cystoscopic valve ablation both have pros and cons for managing posterior urethral valves.

Finasteride improves heart function and repairs damage after heart attack in mice.

Bicalutamide may help treat female pattern hair loss.

Menstrual blood stem cell vesicles show promise for treating various medical conditions.

Finasteride helps improve treatment for benign prostatic hyperplasia.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Higher cholesterol levels increase aggressive prostate cancer risk.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).